Care of Children with Infantile Epileptic Spasms Syndrome and Applicability of Telemedicine Amidst the COVID-19 Pandemic

Indian J Pediatr. 2023 Dec;90(12):1254-1256. doi: 10.1007/s12098-023-04735-1. Epub 2023 Jul 14.

Abstract

This ambispective, observational study evaluated the impact of the COVID-19 pandemic on managing children with Infantile epileptic spasms syndrome (IESS) and the feasibility of telemedicine-based management for IESS. Caregivers of children with IESS were telephonically interviewed using a structured questionnaire and various relevant indices were compared between the study population and a pre-pandemic cohort from the same center. There was a significant increase in diagnostic lag during the pandemic (p = 0.04). Adrenocorticotropic hormone was the first-line antiseizure medication of choice in both cohorts and the response to treatment was also similar. Telemedicine was utilized by around 80% of caregivers and satisfaction rates with telemedicine were high. However, caregivers continued to rate physical consultations higher in preference.

Keywords: COVID-19 pandemic; Infantile epileptic spasms syndrome; Telemedicine; Teleneurology; West syndrome.

Publication types

  • Observational Study

MeSH terms

  • Anticonvulsants / therapeutic use
  • COVID-19* / epidemiology
  • Child
  • Humans
  • Infant
  • Pandemics
  • Spasm / drug therapy
  • Spasm / epidemiology
  • Spasms, Infantile* / drug therapy
  • Syndrome
  • Telemedicine*

Substances

  • Anticonvulsants